empirica wins European Union Project "Reform of Financing Secondary Healthcare" in Bosnia and Herzegovina

empirica"Reform of Financing Secondary Healthcare in Bosnia and Herzegovina" is a project to enhance the efficiency of health care services in Bosnia and Herzegovina by implementing a system of provider payments that would create incentives for cost containment and improve provider performance. It is funded by the European Union, represented by the European Commission, Directorate General EuropeAid Development and Cooperation, and the European Union Delegation to Bosnia and Herzegovina (B&H) on behalf of and for the account of Bosnia and Herzegovina, through the Instrument for Pre-Accession Assistance. Project partners are Karol Consulting, Zagreb, Croatia, and Ericsson Nikola Tesla, Zagreb, Croatia.

The project's aims are to develop an approach towards a Diagnosis Related Groups (DRG) hospital reimbursement system, draft a national DRG pricing and contracting methodology for inpatient care, pilot the data collection process, train staff and finally implement the system in all hospitals. The project will strongly support the long-term reform and sustainability of healthcare services in Bosnia and Herzegovina by facilitating cost containment and, ultimately, contributing towards improved provider performance.

The new reimbursement method, based on outcomes, will provide information on cost-efficiency of the hospital sector. The DRG system will be applied at the level of secondary and tertiary health care and, extended to the entire B&H hospital sector, using existing local resources trained under this project. "Introducing the DRG system will strongly support the ongoing reform of health systems in B&H. empirica, together with its partners Karol Consulting and Ericsson Nikola Tesla, is proud to be part of this significant endeavour," noted Dr. Rainer Thiel of empirica. The implementation of the new DRG system and the incentives that come with it are expected to lead to a more effective healthcare system and cost-efficient spending of resources, at the same time achieving better quality of services. The introduction of the DRG system is also considered as a core component of future hospital information systems.

Related news articles:

About empirica
empirica Communication and Technology Research is a private research institute founded in 1988 and based in Bonn, Germany. It specialises in communication and information technology related research and consultancy to clients in both the private and public sector. Its body of ex-pertise ranges from long-term RTD roadmapping, policy and strategy development to pilot trials and EU-wide representative market research. The company has gained a strong profile in the practical development, pilot-testing and market validation of IST-based healthcare services. It observes and interprets market trends and evaluates the socio-economic impact of eHealth ap-plications. In addition, it regularly conducts foresight exercises, representative surveys and compiles data bases of good practice case studies with the support of a dense network of con-tacts in government, industry and academia. For further information, please visit www.empirica.com.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...